Research Article
Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists
Table 4
Differences between patients who died and survivors.
| | | Patients who died (N=29) | Survivors (N=22) | |
| | Age mean (years) | 78 | 80 | n.s. |
| | SBP mean (mmHg) | 170 | 156 | n.s. |
| | DBP mean (mmHg) | 89 | 81 | n.s. |
| | HR mean (bpm) | 83 | 79 | n.s. |
| | Glycemia mean (mg/dl) | 160 | 132 | n.s. |
| | HASBLED median | 2.8 | 2.4 | n.s. |
| | CHAD2S2-VASc median | 3.5 | 4.23 | n.s. |
| | NIHSS median | 25 | 6.1 | p<0.05 |
| | Leukoaraiosis % | 39% | 47% | n.s. |
| | Intraventricular extension % | 56% | 33% | n.s. |
| | Haemorrhage location N (%) | | | | | (i) Deep | 18.5% | 41.6% | n.s. | | (ii) Lobar | 29.6% | 45.8% | n.s. | | (iii) Intraparenchymal extensive | 14.8% | 8.3% | n.s. | | (iv) Intraventricular | 33.3% | 0 | n.s. | | (v) Brainstem | 0 % | 8.3% | n.s. | | (vi) Cerebellum | 3.7% | 0 % | n.s. |
| | ICH volume (cm3) | 33.9 | 12.5 | p<0.05 |
| | INR on admission (mean) | 3.3 | 2.5 | p<0.05 |
|
|
n.s.: not statistically significant differences. SBP: systolic blood pressure. DBP: diastolic blood pressure. HR: heart rate. VKA: vitamin K antagonist. NIHSS: National Institutes of Health Stroke Scale.
|
